Recruiting NCT04669886

Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.

— Observational Nephrolithiasis Urosepsis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to: Registry conditions: Nephrolithiasis, Urosepsis. Basic parameters: from 18 years · All.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: United States
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

The aim of the study is to establish an infectious risk stratification system based on pre-and post-operative blood endotoxin profile.

Number of participants at each endotoxin activity level after surgery. [Time frame: Day 1 (within 30 minutes postoperative)]
Corelation of endotoxin activity level with post-operative infectious complication [Time frame: up to 24 hours]

Adults that is able to consent (≥ 18 years of age)
Scheduled to undergo PCNL at Uhealth tower and Jackson Memorial Hospitals
not currently immunosuppressed \[White blood count (WBC) >= 2, not on immunosuppressive medications\]

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

United States · 1 center

NCT: NCT04669886 · 20200234